AKRO logo

Akero Therapeutics (AKRO) Shareholders Equity

Annual Shareholders Equity

$750.11 M
+$214.81 M+40.13%

December 31, 2024


Summary


Performance

AKRO Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAKRObalance sheetmetrics:

Quarterly Shareholders Equity

$750.11 M
+$11.79 M+1.60%

December 31, 2024


Summary


Performance

AKRO Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAKRObalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

AKRO Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+40.1%+1.6%
3 y3 years+343.6%+343.6%
5 y5 years+482.7%+482.7%

AKRO Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+343.6%-11.4%+411.9%
5 y5-yearat high+482.7%-11.4%+623.6%
alltimeall timeat high+1602.7%-11.4%+1602.7%

Akero Therapeutics Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$750.11 M(+40.1%)
$750.11 M(+1.6%)
Sep 2024
-
$738.33 M(-7.5%)
Jun 2024
-
$798.07 M(-5.7%)
Mar 2024
-
$846.25 M(+58.1%)
Dec 2023
$535.31 M(+63.9%)
$535.31 M(-8.2%)
Sep 2023
-
$583.13 M(-5.4%)
Jun 2023
-
$616.44 M(+101.2%)
Mar 2023
-
$306.35 M(-6.2%)
Dec 2022
$326.56 M(+93.1%)
$326.56 M(-4.9%)
Sep 2022
-
$343.51 M(+131.5%)
Jun 2022
-
$148.37 M(+1.3%)
Mar 2022
-
$146.53 M(-13.3%)
Dec 2021
$169.11 M
$169.11 M(-14.9%)
DateAnnualQuarterly
Sep 2021
-
$198.63 M(-9.8%)
Jun 2021
-
$220.13 M(-10.5%)
Mar 2021
-
$246.02 M(-4.9%)
Dec 2020
$258.71 M(+101.0%)
$258.71 M(-9.7%)
Sep 2020
-
$286.46 M(+176.3%)
Jun 2020
-
$103.66 M(-12.4%)
Mar 2020
-
$118.32 M(-8.1%)
Dec 2019
$128.73 M(-357.9%)
$128.73 M(-10.2%)
Sep 2019
-
$143.38 M(-9.5%)
Jun 2019
-
$158.39 M(+127.4%)
Mar 2019
-
$69.66 M(-239.6%)
Dec 2018
-$49.92 M(+993.8%)
-$49.92 M
Dec 2017
-$4.56 M
-

FAQ

  • What is Akero Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Akero Therapeutics?
  • What is Akero Therapeutics annual shareholders equity year-on-year change?
  • What is Akero Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Akero Therapeutics?
  • What is Akero Therapeutics quarterly shareholders equity year-on-year change?

What is Akero Therapeutics annual stockholders equity?

The current annual shareholders equity of AKRO is $750.11 M

What is the all time high annual shareholders equity for Akero Therapeutics?

Akero Therapeutics all-time high annual stockholders equity is $750.11 M

What is Akero Therapeutics annual shareholders equity year-on-year change?

Over the past year, AKRO annual stockholders equity has changed by +$214.81 M (+40.13%)

What is Akero Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of AKRO is $750.11 M

What is the all time high quarterly shareholders equity for Akero Therapeutics?

Akero Therapeutics all-time high quarterly stockholders equity is $846.25 M

What is Akero Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, AKRO quarterly stockholders equity has changed by +$11.79 M (+1.60%)